MDimune

ABOUT

SMART DRUG DELIVERY PLATFORM
BASED ON CELL-DERIVED VESICLES

ABOUT
- ABOUT
- OUR SCIENCE
- PIPELINE
- BUSINESS
- NEWS
- CAREERS
About us

About Us

At MDimune, we are passionate about changing the world by developing innovative therapeutics.

History

FOUNDATION ~ 2023

2024

04

Selection of research projects by the Korea Drug Development Fund (KDDF)

02

Publication of joint research papers with LONZA in academic journals

2023

10

Commencement of sales of Umbilical Cord-Derived Stem Cells (MCB, WCB)

07

Commencement of Cell Nanoparticle Analysis Services

06

Certification as an Excellent Enterprise for Job Invention Compensation

05

Publication of 3 research papers for the BioDrone Award in academic journals

04

Acquisition of a Certificate of Registration as a Professional Research Operator (Ministry of Science and ICT)
2023 Edison Awards, Winner of the Health, Medical & Biotech Category Bronze Medal (The Edison Awards)

03

INNO-Biz certification (Ministry of SMEs and Startups)

2022

12

Signed four research collaboration agreement through the 3rd BioDrone Award (Hanyang University)

11

Selected as the next generation of World Class Product of Korea (Ministry of Trade, Industry and Energy)
Signed a technology transfer agreement with Ewha Womans University Medical Center
Signed an MOU with Ewha Womans University Medical Center

10

Signed an MOU with SensoryCure

09

Signed a license and collaboration agreement with Caravan Biologix
Acquired the NET (New Excellent Technology) certification (Ministry of Health and Welfare)

07

Signed an MOU with the Foundation for Medical Innovation (FMI)

05

Acquisition of intellectual property management certification (Korean Intellectual Property Office)
Awarded the Best Small and Medium Business (KBIZ, 2022 Seoul Small and Medium Business Conference)
Acquired the Performance-Sharing Company certification (Ministry of SMEs and Startups)

01

Selected as Youth-Friendly Small-sized Enterprise (Ministry of Employment and Labor)
Signed joint research agreement with YiPSCELL for iPSC-based BioDrone Therapeutics

2021

12

Minister of Science and Technology Citation for contribution to private R&D innovation (Ministry of Science and ICT)
K-BIO Association Chairman’s Award for ‘Bio-Innovation Growth Enterprise’ on Bio Entrepreneur's Day (Ministry of Trade, Industry and Energy)
Signed Global BioDrone Award research collaboration agreement with National University of Singapore

11

Awarded the Minister’s Commendation for Merit: ‘Promoting the Healthcare Industry’ and ‘Commercialization of Healthcare Technologies’. (Ministry of Health and Welfare)
Awarded the Venture and Startup Patent Grand Prize of Korea(Kora Patent Attorneys Association, Maeil Business News Korea)

10

Signed a license and collaboration agreement with Kainos Medicine, Inc. for CDVs (Cell-derived vesicles) mediated delivery of FAF1 mRNA
Research collaboration with NeoCura Bio-Medical Technology Co., Ltd. for the development of mRNA anti-cancer vaccine

09

Research collaboration with Vect-Horus for central nervous system diseases

08

Research collaboration with Seoul National University for Genetic scissors technology

07

Selected for Startup Scale-Up Package as part of the Government's Acceleration Program (Korea Health Industry Development Institute)

06

Awarded the IR52 Jang Young-shil Technology Innovation Award (Ministry of Science and ICT)
Selected for Technological Development Program for Startup Growth as part of the Didimdol Project (Ministry of SMEs and Startups)
Certified for Excellent Job Invention (Korean Intellectual Property Office)

05

Signed a license and collaboration agreement with Reyon Pharmaceutical Co., Ltd. for CDVs (Cell-derived vesicles) mediated delivery of mRNA therapeutics

04

Research collaboration with Navigo Proteins GmbH for development for targeted CDVs (Cell-derived vesicles) delivery
Technology transfer from SNU, Cha Bundang Medical Center (signed MOU with Cha Bundang Medical Center)
Signed technology transfer agreement and MOU with Kyungpook National University

03

Research collaboration with ExonanoRNA, LLC for development of advanced tumor-targeting drug delivery
Research collaboration with Evercyte GmbH for development of tumor-targeting CDVs (Cell-derived vesicles)

2020

12

Minister's Award for job creation on Bio Entrepreneur's Day (Ministry of Trade, Industry and Energy)
Nominated for company research Institute excellence (Ministry of science and ICT)

11

Signed sponsorship of emerging scientists at the 2020 KASBP Fall Symposium
Selected among the 1000 national innovative companies

10

Awarded the Best Cell Therapy Technology of the Year at IMAPC Cell Therapy World Asia 2020
Selected by Lonza to the Startup Creasphere Batch 5 Program
Signed four research collaboration agreement through the 1^st BioDrone Award (Catholic University, Konkuk University, POSTECH)

09

Acquired patents for Cell Extrusion System & Cell Extrusion Technology

08

NET(New Excellent Technology) certification (Ministry of Health and Welfare)

05

Certified for Advanced Technology and Products by the Ministry of Trade, Industry and Energy

04

INNO-Biz certification (Ministry of SMEs and Startups)

03

Acquired a U.S. patent on BioDrone™ platform technology

01

Signed a joint development agreement with Ildong Pharmaceutical Co., Ltd. for anticancer drug based on BioDrone™ technology

2019

12

Certified for the Excellence in Employee Invention Promotion by the Korean Intellectual Property Office
Signed an investment contract with DB Financial Investment

08

Designated DB Financial Investment as an IPO underwriter

06

Signed an investment contract with The Wells Investment

05

Received investments from institutional investors (QUAD Investment Management, STIC VENTURES, KCLAVIS Investment, DAYLI Partners, InterValue Partners)

02

Recruited Dr. Seung Wook Oh as a Chief Scientific Officer

01

Awarded a Youth-friendly Enterprise certification by the Ministry of Employment and Labor

2018

12

Awarded a Post-TIPS (Tech Incubator Program for Startup) grant and Global Marketing grant

05

Signed investment contract with STIC Investments Inc.
Selected as a designated company for alternative military services by Seoul Regional Military Manpower Administration

04

Selected for an Exclusive Consultant Support project for Innovative Biotherapeutics R&D by Korea Food and Drug Administration

03

Awarded the grand prize for the biotech division of the Korea Industrial Enterprise Award by Money Today for the second consecutive year
Signed investment contracts with The Wells Investment, Invest Korea, LNS Venture, and InterValue Partners

2017

12

Signed a joint development agreement with Institute for Refractory Cancer Research at Samsung Medical Center for brain cancer therapeutics

11

Signed a joint development agreement with Hypoxia-related Disease Research Center at Inha University Medical School for brain disease therapeutics

03

Received the grand prize for the biotech division of the Korea Industrial Enterprise Award by Money Today
Signed a business agreement with KBIO Center for New Drug Development at Osong

2016

10

Relocated the headquarters and research center

09

Awarded a TIPS (Tech Incubator Program for Startup) grant by the Small and Medium Business Administration
Selected for an Investors-linked R&D project by Ministry of Trade, Industry and Energy

08

Received investments, including institutional investors

05

Launched an MDimune R&D center under Korea Industrial Technology Association

03

Selected for TIPS (Tech Incubator Program for Startup) by the Small and Medium Business Administration
Signed investment contract with Innopolis Partners, LLC

2015

10